MATINAS BIOPHARMA HOLDINGS, INC.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

MTNB

organization

Jurisdiction: US-DELegal Form: XTIQ

ACTIVE

LEI: 549300TGHXVKQ7EJRO41SIC: 2834

Also known as: Matinas BioPharma Holdings, Inc.

SEC Insider

$6.5M

245 transactions

Summary

MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $3.3MSales: —28 insiders

Date	Insider	Type	Value
2025-04-08	Sanitam Partners LLC	Buy	$703K
2025-04-08	Pembroke & Partners LLC	Buy	$492K
2025-04-08	EIDE ROBERT J	Buy	$492K
2025-04-30	D An Evelyn	A	$0
2025-04-30	Jabbour Jerome D(President and CEO)	A	$0
2025-04-30	Murphy Keith	A	$0
2025-04-30	NEUGEBOREN EDWARD	A	$0
2025-04-30	Smith Robin L	A	$0
2025-04-08	Pembroke & Partners LLC	Buy	—
2025-04-08	EIDE ROBERT J	Buy	—
2025-04-08	Sanitam Partners LLC	Buy	—
2023-12-15	Matkovits Theresa(Chief Development Officer)	A	$0
2023-12-15	Ferguson James J. III(Chief Medical Officer)	A	$0
2023-12-15	Hoover Thomas(Chief Business Officer)	A	$0
2023-12-15	Jabbour Jerome D(President and CEO)	A	$0
2023-12-15	Kucinski Keith A(Chief Financial Officer)	A	$0
2023-12-15	Liu Hui(Chief Technology Officer)	A	$0
2023-11-01	Ende Eric J	A	$0
2023-11-01	CONRAD HERBERT J	A	$0
2023-11-01	Scibetta James S	A	$0

Legal entity: GLEIF

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

MATINAS BIOPHARMA HOLDINGS, INC. — Contributions, Lobbying & Contracts | Poliscope